Cite
Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone.
MLA
Shen, Kai-Ni, et al. “Daratumumab-Based Regimen for Cold Agglutinin Disease Refractory to Therapy Directing B-Cell Clone.” Leukemia & Lymphoma, vol. 65, no. 3, Mar. 2024, pp. 410–12. EBSCOhost, https://doi.org/10.1080/10428194.2023.2287963.
APA
Shen, K.-N., Zhao, D.-Q., Mao, Y.-Y., Cai, H.-C., Li, J., & Cao, X.-X. (2024). Daratumumab-based regimen for cold agglutinin disease refractory to therapy directing B-cell clone. Leukemia & Lymphoma, 65(3), 410–412. https://doi.org/10.1080/10428194.2023.2287963
Chicago
Shen, Kai-Ni, Dan-Qing Zhao, Yue-Ying Mao, Hua-Cong Cai, Jian Li, and Xin-Xin Cao. 2024. “Daratumumab-Based Regimen for Cold Agglutinin Disease Refractory to Therapy Directing B-Cell Clone.” Leukemia & Lymphoma 65 (3): 410–12. doi:10.1080/10428194.2023.2287963.